Lars-Göran Persson1, Agneta Hjalmarson. 1. Health Care Centre of Habo and Development Unit for Primary Health Care, Jönköping, Sweden. lg.persson@lj.se
Abstract
OBJECTIVE: To evaluate an intervention programme on smoking cessation in patients with diabetes mellitus in primary healthcare. DESIGN: Regional controlled intervention study. SETTING:Seventeen primary healthcare centres in Sweden. INTERVENTION: In the intervention centres, nurses with education in diabetes were given one half-day of training in motivational interviewing and smoking cessation. An invitation to participate in a smoking cessation group was mailed to patients from the intervention centres followed by a telephone call from the patient's diabetes nurse. The nurses who intervened were specially educated in smoking cessation. The control group received a letter containing advice to stop smoking and information about a one-year follow-up. PATIENTS: Daily smokers with diabetes mellitus, 30-75 years of age. In the intervention centres 241 patients fulfilled the criteria and in the control centres 171 patients. MAIN OUTCOME MEASURES: Self-reported smoking habits after one year. RESULTS: In total, 21% of the smokers accepted group treatment. After 12 months, 20% (42/211) in the intervention centres reported that they had stopped smoking and 7% (10/140) in the control centres; 40% (19/47) of the smokers who had participated in group treatment reported that they had stopped smoking. CONCLUSION: A computerized record system for patients in primary healthcare was used to identify diabetic patients who were smokers. The selected group was invited to a stop smoking programme. At a one-year follow-up significantly more patients in the intervention centres had stopped smoking compared with patients in the control centres.
RCT Entities:
OBJECTIVE: To evaluate an intervention programme on smoking cessation in patients with diabetes mellitus in primary healthcare. DESIGN: Regional controlled intervention study. SETTING: Seventeen primary healthcare centres in Sweden. INTERVENTION: In the intervention centres, nurses with education in diabetes were given one half-day of training in motivational interviewing and smoking cessation. An invitation to participate in a smoking cessation group was mailed to patients from the intervention centres followed by a telephone call from the patient's diabetes nurse. The nurses who intervened were specially educated in smoking cessation. The control group received a letter containing advice to stop smoking and information about a one-year follow-up. PATIENTS: Daily smokers with diabetes mellitus, 30-75 years of age. In the intervention centres 241 patients fulfilled the criteria and in the control centres 171 patients. MAIN OUTCOME MEASURES: Self-reported smoking habits after one year. RESULTS: In total, 21% of the smokers accepted group treatment. After 12 months, 20% (42/211) in the intervention centres reported that they had stopped smoking and 7% (10/140) in the control centres; 40% (19/47) of the smokers who had participated in group treatment reported that they had stopped smoking. CONCLUSION: A computerized record system for patients in primary healthcare was used to identify diabeticpatients who were smokers. The selected group was invited to a stop smoking programme. At a one-year follow-up significantly more patients in the intervention centres had stopped smoking compared with patients in the control centres.
Authors: Beth C Bock; George D Papandonatos; Marcel A de Dios; David B Abrams; Munawar M Azam; Mark Fagan; Patrick J Sweeney; Michael D Stein; Raymond Niaura Journal: Nicotine Tob Res Date: 2013-10-30 Impact factor: 4.244
Authors: Lydia Roig; Santiago Perez; Gemma Prieto; Carlos Martin; Mamta Advani; Angelina Armengol; Pilar Roura; Josep Maria Manresa; Elena Briones Journal: BMC Public Health Date: 2010-02-04 Impact factor: 3.295
Authors: Renate Jansink; Jozé Braspenning; Ellen Keizer; Trudy van der Weijden; Glyn Elwyn; Richard Grol Journal: Scand J Prim Health Care Date: 2013-06 Impact factor: 2.581
Authors: Pål Hasvold; Marcus Thuresson; Johan Sundström; Niklas Hammar; Sverre E Kjeldsen; Gunnar Johansson; Ingar Holme; Johan Bodegård Journal: Clin Drug Investig Date: 2016-03 Impact factor: 2.859